Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Thalidomide analogue CC-3052 is more active, less toxic than parent drug

Nov. 23, 1998

Phase II data demonstrate efficacy of Avant's rotavirus vaccine

Nov. 23, 1998

SangCya launched in U.S. less than three weeks following approval

Nov. 20, 1998

Intellivax presents promising phase I data for intranasal vaccine for shigellosis

Nov. 20, 1998

New LYMErix study results point to faster immunization

Nov. 19, 1998

Axis Genetics enters collaboration for edible plant vaccine development

Nov. 18, 1998

BTG to commercialize new approach to bacterial vaccines

Nov. 16, 1998

Mizoribine evaluated in children with frequently relapsing nephrotic syndrome

Nov. 13, 1998

New mechanism of action described for immunomodulating agent OM-89

Nov. 12, 1998

Rotavirus vaccine now on the market in U.S.

Nov. 6, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...